Amphastar (AMPH) has announced a multi-year expansion of its U.S. manufacturing operations at its headquarters in Rancho Cucamonga, California. The company plans to quadruple its production capacity at this location over the next three to five years. It will feature a new production plant, expanded automation, and the integration of advanced technologies to support the development and manufacture of critical medications, including supporting the production of new pipeline candidates. Once completed, the company expects to create new jobs in research and development, engineering, manufacturing, and quality operations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPH: